Jiangsu Sihuan Bioengineering Co Ltd (000518) - Net Assets

Latest as of September 2025: CN¥385.48 Million CNY ≈ $56.41 Million USD

Based on the latest financial reports, Jiangsu Sihuan Bioengineering Co Ltd (000518) has net assets worth CN¥385.48 Million CNY (≈ $56.41 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥509.14 Million ≈ $74.50 Million USD) and total liabilities (CN¥123.67 Million ≈ $18.10 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 000518 strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥385.48 Million
% of Total Assets	75.71%
Annual Growth Rate	5.71%
5-Year Change	-41.76%
10-Year Change	-34.45%
Growth Volatility	76.78

Jiangsu Sihuan Bioengineering Co Ltd - Net Assets Trend (1992–2024)

This chart illustrates how Jiangsu Sihuan Bioengineering Co Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see 000518 company net worth.

Annual Net Assets for Jiangsu Sihuan Bioengineering Co Ltd (1992–2024)

The table below shows the annual net assets of Jiangsu Sihuan Bioengineering Co Ltd from 1992 to 2024. Also explore 000518 net assets growth trend to track the company's year-over-year net asset growth rate.

Year	Net Assets	Change
2024-12-31	CN¥398.97 Million ≈ $58.38 Million	-22.19%
2023-12-31	CN¥512.78 Million ≈ $75.04 Million	-13.60%
2022-12-31	CN¥593.50 Million ≈ $86.85 Million	-8.24%
2021-12-31	CN¥646.78 Million ≈ $94.64 Million	-5.59%
2020-12-31	CN¥685.05 Million ≈ $100.24 Million	+3.75%
2019-12-31	CN¥660.31 Million ≈ $96.62 Million	+2.72%
2018-12-31	CN¥642.80 Million ≈ $94.06 Million	-4.85%
2017-12-31	CN¥675.54 Million ≈ $98.85 Million	+10.55%
2016-12-31	CN¥611.10 Million ≈ $89.42 Million	+0.40%
2015-12-31	CN¥608.69 Million ≈ $89.07 Million	-15.65%
2014-12-31	CN¥721.59 Million ≈ $105.59 Million	-1.26%
2013-12-31	CN¥730.78 Million ≈ $106.94 Million	-11.98%
2012-12-31	CN¥830.24 Million ≈ $121.49 Million	-9.34%
2011-12-31	CN¥915.76 Million ≈ $134.00 Million	+4.10%
2010-12-31	CN¥879.72 Million ≈ $128.73 Million	+23.49%
2009-12-31	CN¥712.38 Million ≈ $104.24 Million	+2.82%
2008-12-31	CN¥692.86 Million ≈ $101.39 Million	-16.90%
2007-12-31	CN¥833.76 Million ≈ $122.01 Million	-17.54%
2006-12-31	CN¥1.01 Billion ≈ $147.97 Million	+0.82%
2005-12-31	CN¥1.00 Billion ≈ $146.76 Million	-9.39%
2004-12-31	CN¥1.11 Billion ≈ $161.96 Million	+1.02%
2003-12-31	CN¥1.10 Billion ≈ $160.34 Million	+3.11%
2002-12-31	CN¥1.06 Billion ≈ $155.49 Million	+8.09%
2001-12-31	CN¥983.04 Million ≈ $143.85 Million	+379.92%
2000-12-31	CN¥204.83 Million ≈ $29.97 Million	+30.61%
1999-12-31	CN¥156.83 Million ≈ $22.95 Million	+50.38%
1998-12-31	CN¥104.29 Million ≈ $15.26 Million	-45.09%
1997-12-31	CN¥189.95 Million ≈ $27.80 Million	+5.21%
1996-12-31	CN¥180.55 Million ≈ $26.42 Million	-13.60%
1995-12-31	CN¥208.96 Million ≈ $30.58 Million	-8.59%
1994-12-31	CN¥228.60 Million ≈ $33.45 Million	+8.47%
1993-12-31	CN¥210.74 Million ≈ $30.84 Million	+211.90%
1992-12-31	CN¥67.57 Million ≈ $9.89 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Jiangsu Sihuan Bioengineering Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 73188567100.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Common Stock	CN¥1.03 Billion	276.98%
Other Comprehensive Income	CN¥74.04 Million	19.92%
Total Equity	CN¥371.71 Million	100.00%

Jiangsu Sihuan Bioengineering Co Ltd Competitors by Market Cap

The table below lists competitors of Jiangsu Sihuan Bioengineering Co Ltd ranked by their market capitalization.

Company	Market Cap
OmniAb Inc. NASDAQ:OABI	$574.29 Million
Fastighetsbolaget Emilshus AB ST:EMIL-B	$574.61 Million
ROX Resources Ltd AU:RXL	$574.63 Million
Konka Group Co Ltd SHE:000016	$574.73 Million
Nanfang Ventilator Co Ltd SHE:300004	$573.85 Million
Energy Resources of Australia Ltd AU:ERA	$573.69 Million
Sparebank 1 Ostfold Akershus OL:SOAG	$573.63 Million
Global PMX Co Ltd TW:4551	$573.56 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Jiangsu Sihuan Bioengineering Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 481,706,954 to 371,713,279, a change of -109,993,675 (-22.8%).
Net loss of 109,993,675 reduced equity.
Dividend payments of 600,347 reduced retained earnings.
Other comprehensive income increased equity by 73,429,517.
Other factors decreased equity by 72,829,170.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	CN¥-109.99 Million	-29.59%
Dividends Paid	CN¥600.35K	-0.16%
Other Comprehensive Income	CN¥73.43 Million	+19.75%
Other Changes	CN¥-72.83 Million	-19.59%
Total Change	CN¥-	-22.83%

Book Value vs Market Value Analysis

This analysis compares Jiangsu Sihuan Bioengineering Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 10.56x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 58.66x to 10.56x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
1992-12-31	CN¥0.06	CN¥3.81	x
1993-12-31	CN¥0.20	CN¥3.81	x
1994-12-31	CN¥0.22	CN¥3.81	x
1995-12-31	CN¥0.20	CN¥3.81	x
1996-12-31	CN¥0.17	CN¥3.81	x
1997-12-31	CN¥0.18	CN¥3.81	x
1998-12-31	CN¥0.10	CN¥3.81	x
1999-12-31	CN¥0.15	CN¥3.81	x
2000-12-31	CN¥0.20	CN¥3.81	x
2001-12-31	CN¥0.94	CN¥3.81	x
2002-12-31	CN¥1.02	CN¥3.81	x
2003-12-31	CN¥1.05	CN¥3.81	x
2004-12-31	CN¥1.06	CN¥3.81	x
2005-12-31	CN¥0.96	CN¥3.81	x
2006-12-31	CN¥1.26	CN¥3.81	x
2007-12-31	CN¥0.81	CN¥3.81	x
2008-12-31	CN¥0.67	CN¥3.81	x
2009-12-31	CN¥0.69	CN¥3.81	x
2010-12-31	CN¥0.69	CN¥3.81	x
2011-12-31	CN¥0.69	CN¥3.81	x
2012-12-31	CN¥0.73	CN¥3.81	x
2013-12-31	CN¥0.66	CN¥3.81	x
2014-12-31	CN¥0.66	CN¥3.81	x
2015-12-31	CN¥0.59	CN¥3.81	x
2016-12-31	CN¥0.59	CN¥3.81	x
2017-12-31	CN¥0.61	CN¥3.81	x
2018-12-31	CN¥0.58	CN¥3.81	x
2019-12-31	CN¥0.60	CN¥3.81	x
2020-12-31	CN¥0.62	CN¥3.81	x
2021-12-31	CN¥0.59	CN¥3.81	x
2022-12-31	CN¥0.54	CN¥3.81	x
2023-12-31	CN¥0.47	CN¥3.81	x
2024-12-31	CN¥0.36	CN¥3.81	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Jiangsu Sihuan Bioengineering Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -29.59%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -54.05%
• Asset Turnover: 0.36x
• Equity Multiplier: 1.53x
Recent ROE (-29.59%) is below the historical average (-2.25%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
1992	9.52%	8.74%	0.58x	1.88x	CN¥-322.59K
1993	9.80%	32.76%	0.24x	1.22x	CN¥-414.92K
1994	8.12%	22.45%	0.29x	1.25x	CN¥-4.26 Million
1995	-6.84%	-24.16%	0.23x	1.25x	CN¥-35.19 Million
1996	-15.99%	-34.27%	0.30x	1.53x	CN¥-46.53 Million
1997	3.12%	2.80%	0.69x	1.61x	CN¥-12.79 Million
1998	-29.96%	-6152.86%	0.00x	1.73x	CN¥-41.67 Million
1999	24.69%	36.79%	0.49x	1.38x	CN¥23.04 Million
2000	25.88%	28.31%	0.68x	1.34x	CN¥32.53 Million
2001	7.79%	20.83%	0.34x	1.10x	CN¥-21.62 Million
2002	8.09%	18.23%	0.41x	1.08x	CN¥-20.21 Million
2003	6.32%	18.36%	0.31x	1.13x	CN¥-40.24 Million
2004	1.02%	3.60%	0.22x	1.26x	CN¥-99.11 Million
2005	-10.36%	-50.33%	0.16x	1.30x	CN¥-203.52 Million
2006	0.71%	2.55%	0.23x	1.22x	CN¥-93.34 Million
2007	-21.33%	-62.87%	0.32x	1.07x	CN¥-259.73 Million
2008	-20.30%	-77.96%	0.23x	1.13x	CN¥-208.78 Million
2009	3.28%	12.03%	0.26x	1.06x	CN¥-47.90 Million
2010	1.07%	3.67%	0.22x	1.34x	CN¥-63.99 Million
2011	-0.84%	-2.44%	0.25x	1.37x	CN¥-77.01 Million
2012	1.35%	3.84%	0.29x	1.22x	CN¥-64.52 Million
2013	-10.47%	-33.88%	0.25x	1.22x	CN¥-138.22 Million
2014	0.87%	2.47%	0.29x	1.20x	CN¥-62.15 Million
2015	-12.27%	-31.30%	0.29x	1.38x	CN¥-135.11 Million
2016	0.73%	1.37%	0.32x	1.66x	CN¥-56.64 Million
2017	1.16%	2.11%	0.37x	1.48x	CN¥-55.58 Million
2018	-4.91%	-7.44%	0.43x	1.55x	CN¥-89.36 Million
2019	2.34%	3.43%	0.46x	1.49x	CN¥-47.02 Million
2020	4.26%	5.40%	0.61x	1.29x	CN¥-36.79 Million
2021	-6.32%	-10.90%	0.44x	1.32x	CN¥-98.87 Million
2022	-9.56%	-19.72%	0.37x	1.32x	CN¥-109.01 Million
2023	-15.63%	-31.97%	0.36x	1.37x	CN¥-123.44 Million
2024	-29.59%	-54.05%	0.36x	1.53x	CN¥-147.17 Million

Industry Comparison

This section compares Jiangsu Sihuan Bioengineering Co Ltd's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $2,412,088,398
Average return on equity (ROE) among peers: 7.91%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Jiangsu Sihuan Bioengineering Co Ltd (000518)	CN¥385.48 Million	9.52%	0.32x	$574.00 Million
Shenzhen CAU Technology Co Ltd (000004)	$99.94 Million	-13.59%	0.56x	$9.88 Million
Pacific Shuanglin Bio pharmacy Co Ltd (000403)	$235.63 Million	9.07%	1.22x	$1.38 Billion
Nanhua Bio Medicine Co Ltd (000504)	$357.51 Million	8.06%	1.77x	$439.46 Million
Chengzhi Shareholding Co Ltd (000990)	$1.02 Billion	4.98%	1.21x	$1.58 Billion
Hualan Biological EngineeringInc (002007)	$8.10 Billion	19.91%	0.24x	$3.41 Billion
Da An Gene Co Ltd of Sun Yat-Sen University (002030)	$9.16 Billion	1.14%	0.20x	$1.08 Billion
Shanghai RAAS Blood Products Co Ltd Class A (002252)	$927.27 Million	21.61%	0.09x	$4.73 Billion
Baolingbao Biology Co Ltd (002286)	$662.61 Million	5.93%	0.64x	$428.70 Million
Tibet Cheezheng Tibetan Medicine Co Ltd (002287)	$1.14 Billion	14.05%	0.13x	$1.61 Billion

About Jiangsu Sihuan Bioengineering Co Ltd

SHE:000518 China Biotechnology

Market Cap

$574.00 Million

CN¥3.92 Billion CNY

Market Cap Rank

#11604 Global

#3285 in China

Share Price

CN¥3.81

Change (1 day)

+0.53%

52-Week Range

CN¥2.25 - CN¥4.54

All Time High

CN¥9.49